Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells
Cancer Genomics - Proteomics · 2025
DOI: 10.21873/cgp.20490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Nanke Murra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Tretinoin, Chemokine CCL2, Neuroblastoma, N-Myc Proto-Oncogene Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany vicki.waetzig@pharmakologie.uni-kiel.de.
Zitieren
APA
Murra, N., Pommert, N. S., Schmidt, B., Issa, R. S., Kaehler, M., Bruckmueller, H., Tim, V., Cascorbi, I., & Waetzig, V. (2025). Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20490
Vancouver
Murra N, Pommert NS, Schmidt B, Issa RS, Kaehler M, Bruckmueller H, et al. Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20490
BibTeX
@article{Murra2025,
author = {Murra, Nanke and Pommert, Nina Sophie and Schmidt, Berit and Issa, Reema Sami and Kaehler, Meike and Bruckmueller, Henrike and Tim, Vera and Cascorbi, Ingolf and Waetzig, Vicki},
title = {Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells},
journal = {Cancer Genomics - Proteomics},
year = {2025},
doi = {10.21873/cgp.20490}
}
EUVIMED